Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00826
Species: Homo sapiens
Position : chr20:44478646-44484559
Year: 2011
Title: Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: prostate cancer
PMID:  21556051
MONDO: MONDO:0008315
Tissue: prostate gland
Tissue Ontology ID: UBERON:0002367
Cell Source: PC-3
CVCL ID: CVCL_0035
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay; TF-binding/chromatin assay; Chromatin interaction assay; Disease-associated enhancer analysis
Low Throughput Method: Luciferase reporter assay; Reporter assay; ChIP-qPCR/ChIP; 3C; Western blot
About Target Gene
Target gene : UBE2C
About TF
TF name : FOXA1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
FOXA1 AndrogenReceptor netpath 167
FOXA1 Direct p53 effectors pid 141
FOXA1 FOXA1 transcription factor network pid 45
FOXA1 FOXA2 and FOXA3 transcription factor networks pid 45
FOXA1 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
Enhancer Associated Network
Overlapping Enhancers (hg19) 7 found
Enhancer ID Position Tissue Cell Disease
E_00823 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00824 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00825 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00827 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00828 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00829 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00830 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
Expression of Target Genes for the Enhancer